LAMIVUDINE TEVA PHARMA B.V. 300 mg, comprimé pelliculé — pilulier(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400938244861
  • CIP7 3824486
  • CIS 61785366
  • Registration number EU/1/09/596

What the source publishes

Holder
TEVA (PAYS-BAS)
Active ingredients
LAMIVUDINE
Form
comprimé pelliculé
Package
pilulier(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2009-12-10
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400938244861
{
  "cis": "61785366",
  "cip7": "3824486",
  "form": "comprimé pelliculé",
  "name": "LAMIVUDINE TEVA PHARMA B.V. 300 mg, comprimé pelliculé — pilulier(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)",
  "cip13": "3400938244861",
  "holder": "TEVA (PAYS-BAS)",
  "routes": [
    "orale"
  ],
  "holders": [
    "TEVA (PAYS-BAS)"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "64.83",
  "authorisedOn": "2009-12-10",
  "compositions": [
    {
      "name": "LAMIVUDINE",
      "nature": "SA",
      "strength": "300 mg",
      "linkageNumber": "1",
      "substanceCode": "17878",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription initiale hospitalière annuelle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "63.81",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "LAMIVUDINE TEVA PHARMA B.V. 300 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "pilulier(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2021-11-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "LAMIVUDINE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "prescription initiale hospitalière annuelle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/09/596",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400938244861"